- Top
- Drug Discovery Consulting
“Beyond AI Consulting. Real Drug Discovery”
“Evidence-Based” Drug Discovery Consulting That Goes Beyond AI
Successful drug discovery requires not only knowledge but also “verifiable technology.”
We set ourselves apart from traditional consulting firms that merely “organize information and offer advice.” Leveraging our proprietary, proven analytical platforms and measurement technologies, we provide hands-on drug discovery support—from hypothesis building to target identification, mechanism-of-action analysis, and drug evaluation—where we actively engage to deliver tangible results.
・Our Strengths
・Services We Offer
・Consulting Formats
Our Strengths
- 1. Track Record in Drug Discovery
- ・We have a track record of advancing drugs developed in-house to physician-led clinical trials.
- ・We provide support for challenges arising at each stage of drug discovery, drawing on our track record and experience.
- 2. Proprietary and Patented Technologies
- ・We possess proprietary, patented computational platforms.
- ・Through multifaceted network analysis and phosphorylation signaling analysis, we identify mechanisms of action and novel targets that cannot be detected by AI alone.
- 3. Extensive Experience Supporting Pharmaceutical Companies
- ・We have accumulated expertise through collaborative research and analytical support with numerous pharmaceutical companies.
- ・We provide comprehensive support, ranging from research strategy to experimental design and data analysis.
- 4. Proprietary Phosphorylation Proteome Analysis
- ・We possess a proprietary phosphorylation array platform. It is used by research institutions both in Japan and abroad and has contributed to numerous academic papers.
- ・By integrating kinase activity, signal transduction, mechanisms of drug action, and off-target analysis, we can accurately assess the overall picture of phosphorylation—which cannot be seen through individual analyses.
We combine these “strengths” with the goal of not merely “analyzing and stopping there,” but rather “demonstrating results and driving outcomes.”
Services We Offer
- ・Drug Discovery Target Identification
- ・AI-Driven Drug Discovery Strategy Development
- ・Analysis of Drug Mechanisms of Action (MoA)
- ・Phosphorylation Signal Analysis
- ・Off-Target Analysis
- ・Biomarker Discovery
- ・Differentiation from other companies’ marketed drugs
- ・Strategies for Expanding Clinical Indications
- ・Patent Strategy Support
- ・R&D Strategy Consulting
- ・Support for Academic Papers and Research Grant Applications
(“Except for considerations regarding authorship in academic papers under ‘Support for Academic Papers and Research Grant Applications’, our company makes no claims to any rights whatsoever.”)
Consulting Formats
♦Three Consulting Models
- ① Hands-On (Short-Term): Includes measurement, analysis, and explanation using our proprietary technology. →Single-Problem-Solving Approach [up to 3 months]
- ② Hands-On (Long-Term): Problem-sharing and resolution based on the repeated evaluation of your company’s data following the results of ① →Collaborative Problem-Solving Approach [3 months or more]
- ③ Review-Based: Evaluation and explanation of your company’s data using our proprietary technology [up to 3 months]
